POSC63 Cost-Effectiveness of Non-Statin Lipid-Modifying Agents for Primary and Secondary Prevention of Cardiovascular Disease Among Patients with Type 2 Diabetes Mellitus: A Systematic Review

Autor: Abushanab, D, Al-Badriyeh, D, Marquina, C, Bailey, C, Jaam, M, Liew, D, Ademi, Z
Zdroj: In Value in Health January 2022 25(1) Supplement:S98-S98
Databáze: ScienceDirect